Skip to content

These companies are the top lobbying spenders in 2023

These companies are the top lobbying spenders in 2023

In recent years, corporate lobbying has become an increasingly prominent aspect of the political landscape, with companies allocating substantial resources to influence government decisions. 

This strategic practice involves companies advocating for policies that align with their interests through various means, such as direct communication with lawmakers and financial contributions. 

The surge in corporate lobbying expenditures underscores a growing recognition among businesses of the impact government policies can have on their operations and profitability. In 2022, federal lobbying costs reached $4.1 billion, the highest since 2010. 

In this light, today, on November 20, we delve into the data to unravel the intricacies of which US companies have been spending the most money for lobbying purposes. 

Meta and Amazon top the 2023 chart

In 2023, top lobbying spenders have already poured hundreds of millions of dollars.

For now, the two companies that top the list by some distance are tech giants Meta Platforms (NASDAQ: META) and Amazon (NASDAQ: AMZN). According to data provided by Quiver Quantitative on November 18, Meta and Amazon spent around $15 million and $13 million year-to-date, respectively.

Top corporate lobbying spenders in 2023. Source: Quiver Quantitative

The third-biggest spender is aircraft-making behemoth Boeing (NYSE: BA), while the fourth and fifth place belongs to Lockheed Martin (NYSE: LMT) and General Motors (NYSE: GM). Each of the three companies allocated over $10 million for corporate lobbying this year. 

Completing the roster of the top 10 lobbying spenders are CVS Health (NYSE: CVS), Pfizer (NYSE: PFE), Google owner Alphabet (NASDAQ: GOOGL), General Dynamics (NYSE: GD), and Verizon (NYSE: VZ).

Senators demand more information on corporate lobbying

Last week, five Democrats who sit on the Senate Banking Committee urged the Securities and Exchange Commission (SEC) to require companies to share more details on their corporate lobbying strategies with shareholders. 

In their letter to the SEC, the senators asked the SEC to create a new rule that would “require registered companies to disclose, as relevant, any lobbying strategy, the aggregate amount of direct or indirect contributions to registered state and federal lobbyists, and any material risks related to or arising from the registrant’s lobbying strategy and expenditures.”

The lawmakers gave the SEC until November 29 to offer details on the plan. 

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.